Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02200848
Brief Title: Phase I Study of Lenalidomide, Rituximab and Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

First Submitted : July 22, 2014
First Submitted that Met QC Criteria : July 24, 2014
First Posted : July 25, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : January 10, 2018
Last Update Posted : January 12, 2018